-
Mashup Score: 1
The data indicate it’s worth a shot to try TEER in many with secondary MR, but clinical judgement is critical.
Source: www.tctmd.comCategories: General Medicine NewsTweet
-
Mashup Score: 0Roughly Half of Patients Don’t Have Symptoms Prior to a First MI - 11 hour(s) ago
The findings from a contemporary US cohort point to the need for better ways to identify and treat those who are at risk.
Source: www.tctmd.comCategories: General Medicine NewsTweet
-
Mashup Score: 2The Hidden Demands of Cardiology Training - 16 hour(s) ago
Perhaps it’s time to rethink how much personal sacrifice is necessary in the name of learning to become a physician.
Source: www.tctmd.comCategories: General Medicine NewsTweet
-
Mashup Score: 0The STEEER-AF Trial - 18 hour(s) ago
Dipak Kotecha talks to C. Michael Gibson about whether educating healthcare providers on rhythm-control therapy affects guideline adherence and stroke outcomes.
Source: www.tctmd.comCategories: General Medicine NewsTweet
-
Mashup Score: 5
Some believe that future studies are still needed to tease out whether there are high-risk subgroups who will benefit.
Source: www.tctmd.comCategories: General Medicine NewsTweet
-
Mashup Score: 5
The benefit seems durable, but one expert says patients should be aware there’s “some risk of stroke” during the procedure.
Source: www.tctmd.comCategories: General Medicine NewsTweet
-
Mashup Score: 1CMS Agrees to Reimburse Tricuspid TEER - 3 day(s) ago
The overall evidence for the procedure is “insufficient” at present, but good enough to allow coverage, the agency says.
Source: www.tctmd.comCategories: General Medicine NewsTweet
-
Mashup Score: 2
The study led to questions about whether patients would be best served by being treated at high-volume centers of excellence.
Source: www.tctmd.comCategories: General Medicine NewsTweet
-
Mashup Score: 7
Only a minority consistently meet timely targets set out by the AHA and ACC. This is a “call to action,” Harold Dauerman says.
Source: www.tctmd.comCategories: General Medicine NewsTweet
-
Mashup Score: 7
Only a minority consistently meet timely targets set out by the AHA and ACC. This is a “call to action,” Harold Dauerman says.
Source: www.tctmd.comCategories: General Medicine NewsTweet
A recent study in #JACCHF confirms the safety & efficacy of M-TEER with #MitraClip in patients with #vhdMR who don’t meet the COAPT study inclusion criteria. Get the details: https://t.co/gfjjjPGtm5